Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haoxi Health Technology (HAO) Notes Payables (2023 - 2025)

Haoxi Health Technology's Notes Payables history spans 3 years, with the latest figure at $1.3 million for Q4 2025.

  • Quarterly Notes Payables rose 14.16% to $1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, up 14.16% year-over-year, with the annual reading at $1.3 million for FY2025, 56.92% up from the prior year.
  • Notes Payables came in at $1.3 million for Q4 2025, down from $1.3 million in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $1.3 million in Q2 2025 to a low of $511409.0 in Q2 2023.
  • The 3-year median for Notes Payables is $1.1 million (2024), against an average of $1.0 million.
  • Year-over-year, Notes Payables soared 62.99% in 2024 and then increased 14.16% in 2025.
  • Haoxi Health Technology's Notes Payables stood at $511409.0 in 2023, then skyrocketed by 119.33% to $1.1 million in 2024, then grew by 14.16% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for HAO's Notes Payables are $1.3 million (Q4 2025), $1.3 million (Q2 2025), and $1.1 million (Q4 2024).